David Rosmarin

16PUBLICATIONS
40CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsBusiness information management (incl. records, knowledge and intelligence)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication.

David Rosmarin, Thierry Passeron, Amit G Pandya

|Mar 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies.

Julien Seneschal, Albert Wolkerstorfer, Seemal R Desai

|Sep 19, 2024
Coverage of Specialty Drugs for Psoriasis and Psoriatic Arthritis by Commercial Insurance Companies.

Christine Learned, Sara Alsukait, Kristin R Fiumara

|Aug 13, 2024
Healthcare Resource Use and Costs Among Individuals with Vitiligo and Psychosocial Comorbidities: Retrospective Analysis of an Insured US Population.

Jennifer H Lofland, Samyuktha Darbha, Ahmad B Naim

|Jun 02, 2024
Health-Related Quality of Life Burden Among Adults with Vitiligo: Relationship to Disease Severity and Disease Location.

David Rosmarin, Ahmed M Soliman, James Piercy

|May 16, 2024
Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients.

David Rosmarin, Jennifer H Lofland, Simran Marwaha

Pageof 3

Frequent Collaborators

4 joint publications

Deanna Kornacki

3 joint publications

Amit G Pandya

3 joint publications

Pearl Grimes

3 joint publications

Khaled Ezzedine